Correlation Between Pmv Pharmaceuticals and Corvus Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Corvus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Corvus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and Corvus Pharmaceuticals, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Corvus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Corvus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Corvus Pharmaceuticals.

Diversification Opportunities for Pmv Pharmaceuticals and Corvus Pharmaceuticals

0.69
  Correlation Coefficient

Poor diversification

The 3 months correlation between Pmv and Corvus is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Corvus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corvus Pharmaceuticals and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Corvus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corvus Pharmaceuticals has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Corvus Pharmaceuticals go up and down completely randomly.

Pair Corralation between Pmv Pharmaceuticals and Corvus Pharmaceuticals

Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to under-perform the Corvus Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Pmv Pharmaceuticals is 1.89 times less risky than Corvus Pharmaceuticals. The stock trades about -0.05 of its potential returns per unit of risk. The Corvus Pharmaceuticals is currently generating about 0.25 of returns per unit of risk over similar time horizon. If you would invest  202.00  in Corvus Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of  692.00  from holding Corvus Pharmaceuticals or generate 342.57% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy99.21%
ValuesDaily Returns

Pmv Pharmaceuticals  vs.  Corvus Pharmaceuticals

 Performance 
       Timeline  
Pmv Pharmaceuticals 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Pmv Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, Pmv Pharmaceuticals is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Corvus Pharmaceuticals 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Corvus Pharmaceuticals are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Corvus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pmv Pharmaceuticals and Corvus Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pmv Pharmaceuticals and Corvus Pharmaceuticals

The main advantage of trading using opposite Pmv Pharmaceuticals and Corvus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Corvus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corvus Pharmaceuticals will offset losses from the drop in Corvus Pharmaceuticals' long position.
The idea behind Pmv Pharmaceuticals and Corvus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated